Bhaskar Chaudhuri - Apr 20, 2021 Form 4/A - Amendment Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Bhaskar Chaudhuri
Stock symbol
ARQT
Transactions as of
Apr 20, 2021
Transactions value $
-$280,568
Form type
4/A - Amendment
Date filed
5/19/2021, 06:43 PM
Date Of Original Report
Apr 22, 2021
Next filing
Jun 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale -$244K -8.72K -1% $27.99 863K Apr 20, 2021 Direct F1, F2, F5
transaction ARQT Common Stock Sale -$36.5K -1.28K -0.15% $28.53 861K Apr 20, 2021 Direct F1, F3, F5
holding ARQT Common Stock 50K Apr 20, 2021 By Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $27.50 to $28.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The transaction was executed in multiple trades in prices ranging from $28.50 to $28.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F5 The Form 4/A filed by the Reporting Person on 5/12/2021 was filed in error. The original Form 4 filed by the Reporting Person on 04/22/2021 accurately reported the transactions as they occurred. This Form 4/A corrects the aforementioned error by restating the original Form 4 in its entirety.

Remarks:

Exhibit 24.1 - Power of Attorney